Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

GW Pharma High On Epilepsy Results, Plans 2017 NDA

Executive Summary

The biotech announces another set of positive anti-seizure results for its marijuana-derived product.

Advertisement

Related Content

Deal Watch: DelMar Takes On Unmet Need In Brain Cancer With Accurexa
GW Pharmaceuticals High On Epilepsy Data

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC065523

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel